Aims This meta-analysis aims to analyze the association of calcium channel blocker (CCB)
use with COVID-19 clinical outcomes. Methods PubMed, ProQuest, Science Direct, Scopus …

We aimed to perform a systematic review and meta-analysis to determine the overall effect
of the preadmission/prediagnosis use of calcium channel blockers (CCBs) on the clinical …

Background: Hypertension is considered an important risk factor for the coronavirus disease
2019 (COVID-19). The commonly anti-hypertensive drugs are the renin-angiotensin …

With the rising numbers of patients infected with severe acute respiratory syndrome
coronavirus 2, long coronavirus disease 2019 (COVID-19)—a sequelae of COVID-19—has …

Methods Among 444 consecutively hospitalized patients with confirmed COVID-19 (admitted
between March 13 and April 7, 2020, at a quaternary referral center and an affiliated …

Abstract The coronavirus disease (COVID-19) caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has now spread to> 200 countries posing a global …

Background The association of antihypertensive drugs with the risk and severity of COVID-
19 remains unknown. Methods and Results We systematically searched PubMed …

This study aimed to investigate whether specific medications used in the treatment chronic
diseases affected either the development and/or severity of coronavirus disease 2019 …

Background and aims COVID-19 is already a pandemic. Emerging data suggest an
increased association and a heightened mortality in patients of COVID-19 with …

Purpose The role of angiotensin receptor blockers (ARB), angiotensin-converting enzyme
inhibitors (ACEi), or other antihypertensive agents in the case of Covid-19 remains …